Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety

• Status: Recruiting
• Trial end date: 2022-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the clinical efficacy and neuro-cognitive mechanisms of Gaze-Contingent Usic Reward Therapy for social anxiety disorder, compared with treatment with SSRIs or waitlist control.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tel Aviv University
• Collaborators: Sheba Medical Center; Tel-Aviv Sourasky Medical Center
• Treatments: Citalopram; Dexetimide; Serotonin Uptake Inhibitors

Criteria

Inclusion Criteria:

• A signed consent form

• Men and women between the ages of 18 and 65.

• Meeting a current diagnosis of Social Anxiety Disorder (SP) according to the DSM-IV.

• SP as the primary diagnosis: In cases of co-morbidity, SP will be deemed as the most distressing and clinically significant condition among the co-morbid disorders.

• No current pharmaco-therapy.

Exclusion Criteria:

• A diagnosis of psychotic or bipolar disorders.

• A diagnosis of a neurological disorder (i.e., epilepsy, brain injury).

• Drug or alcohol abuse.

• Any current pharmacological treatment.

• Any current psychotherapeutic treatment.

• Change in treatment during the study.

• Poor judgment capacity (i.e., children under 18 and special populations).